About Inspire Medical Systems Inc
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.inspiresleep.com/
Frequently Asked Questions
What is the 52-week range for INSP?
The 52-week high is $147.03 and the 52-week low is $38.91.
What is the P/E ratio for INSP?
The Price to Earnings (P/E) ratio is 15.14.
What is the dividend yield for INSP?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 17.62%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 15.03%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.43.
Analyst Recommendation Trends
Wall Street analyst consensus for INSP over the last few months:
Latest INSP News
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that the American Medical Association (AMA) CPT® Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT®) codes that accurately describe and include the Inspire V syste
Inspire Medical Systems Receives American Medical Association CPT Editorial Panel Approval To Establish New Set Of Current Procedural Terminology Codes
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea
RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75
RBC Capital analyst Kendall Au maintains Inspire Medical Systems (NYSE:INSP) with a Sector Perform and raises the price target from $60 to $75.
Inspire Medical Systems (INSP) Stock Could Be A Bargain On Cash Flow
Inspire Medical Systems has seen its share price fall sharply over several years, and that slide raises a pointed question about whether the current market value still lines up with the cash the business is expected to generate. With the stock now well below past peaks, the key issue is how today’s US$69.36 price compares with its future cash flow profile. The share price decline of 71.2% over 5 years puts long term expectations for Inspire Medical Systems’ cash generation under the...
Inspire Medical Systems (INSP) Faces A Rebound Question As Fair Value Stays In Focus
Inspire Medical Systems (INSP) has been drawing attention after a sharp move in its share price, with the stock last closing at US$70. That shift is prompting fresh questions about how investors are treating this sleep apnea specialist. Recent trading tells a mixed story for Inspire Medical Systems. The share price has surged with a 56.9% 90 day return and 13.9% 1 month gain; yet momentum is fading near term with the 7 day share price return down 7.6% and the year to date share price return...
Is ResMed A Better Way Than Stryker To Own Medical Device Growth?
Stryker's sales have grown about 10% a year on average over the past three years, and so have ResMed's. That shared growth rate in medical devices is the bet the two have in common. Stryker (SYK) is the giant, selling hospitals everything from hip and knee products to capital equipment. ResMed is a sleep device maker with less than a quarter of Stryker's revenue. Stryker costs 32.6 times its past year's earnings, against 21.9 times for ResMed. So does Stryker's reach justify that higher price? T
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Inspire Medical is navigating a major product transition as clinical evidence, patient access efforts and reimbursement progress support growth prospects.
Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure
DGX study finds nearly one-third of Lyme-seropositive patients had antibodies to another tick-borne pathogen, highlighting broader testing needs.
1 Momentum Stock to Target This Week and 2 That Underwhelm
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.
OPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026?
OPKO Health is gaining on pharmaceutical growth, a broad clinical pipeline, strategic partnerships and fresh non-dilutive financing.
Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised targets for INSP, SECZ, CLF and WAT, while cutting targets for CRDO, CL and TTMI; ratings remained unchanged.
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97
Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $71 to $97.
Waters Launches BD FACSDiscover A7 for Advanced Flow Cytometry
WAT launches the BD FACSDiscover A7 globally, bringing advanced spectral flow cytometry, automation and standardized workflows to research labs.
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
West Pharmaceutical's biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.
Stryker Expands Foot & Ankle Innovation With Prophecy and smartHEX
SYK expands its Foot & Ankle portfolio with Prophecy for Incompass and smartHEX, linking planning, implants and limb reconstruction.
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CONMED's BioBrace and AirSeal platforms, robotic growth and easing supply bottlenecks support its long-term outlook despite tariff headwinds.
GEHC Launches CareIntellect AI Tool to Optimize Hospital Operations
GE HealthCare launches an AI-powered SaaS tool that predicts hospital capacity challenges up to 72 hours ahead and recommends actions to ease bottlenecks.
Inspire Medical Systems (INSP) Stock Could Be 14% Undervalued On Cash Flow
Inspire Medical Systems has seen its share price move sharply over several timeframes, which naturally puts the focus on whether the current valuation is supported by the cash it can generate. With the stock price at US$74.32 at the last close, the key issue now is how that market tag lines up with the business’s future cash flows. Over the past 5 years, Inspire Medical Systems shares have fallen 70.2%, which puts a lot of weight on whether the underlying cash flow story still backs the...
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.
Why Inspire Medical Systems (INSP) Stock Is Up Today
Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 7.4% in the morning session after Stifel analyst Jonathan Block raised the price target on the company to $80.00 from $75.00 while maintaining a Buy rating.
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.
Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80
Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $75 to $80.
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
Inspire Medical, Cybin and Aveanna show overbought RSI readings above 70, signaling potential momentum warnings for healthcare investors.
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q2 Earnings?
Inspire Medical Systems currently trades at $62.14 per share and has shown little upside over the past six months, posting a small loss of 3.4%. The stock also fell short of the S&P 500’s 11.7% gain during that period.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-31 | Kelly Jason P | +6,350 | - | - |
| 2026-08-07 | Kelly Jason P | -963 | $59.55 | $57,347 |
| 2026-07-31 | Mann Melissa | -326 | $50.21 | $16,368 |
| 2026-07-20 | CARREL MICHAEL H | +5,631 | - | - |
| 2026-07-15 | Melenikiotou Georgia | +344 | - | - |
| 2026-07-15 | Tansey Casey M | +346 | - | - |
| 2026-07-15 | Broader Shelley G | +383 | - | - |
| 2026-07-15 | Ellis Gary Lee | +581 | - | - |
| 2026-05-15 | Rondoni John | -2,641 | $43.28 | $114,302 |
| 2026-05-14 | Rondoni John | -700 | $43.01 | $30,107 |
| 2026-05-08 | mcCormick Shawn | -696 | $45.31 | $31,536 |
| 2026-05-01 | Melenikiotou Georgia | -50 | $56.7 | $2,835 |
| 2026-04-30 | Curet Myriam | +3,562 | - | - |
| 2026-04-30 | Burks Cynthia | +3,562 | - | - |
| 2026-04-30 | Melenikiotou Georgia | +3,562 | - | - |
| 2026-04-30 | Tansey Casey M | +3,562 | - | - |
| 2026-04-30 | mcCormick Shawn | +3,562 | - | - |
| 2026-04-30 | Broader Shelley G | +3,562 | - | - |
| 2026-04-30 | Ellis Gary Lee | +3,562 | - | - |
| 2026-04-30 | Mead Dana G Jr. | +3,562 | - | - |
| 2026-04-15 | Melenikiotou Georgia | +307 | $52.07 | $15,985 |
| 2026-04-15 | Tansey Casey M | +308 | $52.07 | $16,038 |
| 2026-04-15 | Broader Shelley G | +342 | $52.07 | $17,808 |
| 2026-04-15 | Ellis Gary Lee | +518 | $52.07 | $26,972 |
| 2026-02-20 | Herbert Timothy P. | +62,153 | - | - |
| 2026-02-20 | Herbert Timothy P. | -4,010 | $59.53 | $238,715 |
| 2026-02-20 | Herbert Timothy P. | +9,005 | - | - |
| 2026-02-20 | Kelly Jason P | +15,958 | - | - |
| 2026-02-20 | Mann Melissa | +15,958 | - | - |
| 2026-02-20 | Weatherby Carlton | +12,598 | - | - |
| 2026-02-20 | Weatherby Carlton | +20,997 | - | - |
| 2026-02-20 | Weatherby Carlton | -672 | $59.53 | $40,004 |
| 2026-02-20 | Weatherby Carlton | +2,196 | - | - |
| 2026-02-20 | Rondoni John | +15,958 | - | - |
| 2026-02-20 | Rondoni John | -735 | $59.53 | $43,755 |
| 2026-02-20 | Rondoni John | +2,400 | - | - |
| 2026-02-20 | Phillips Bryan K | +8,399 | - | - |
| 2026-02-20 | Phillips Bryan K | +15,958 | - | - |
| 2026-02-20 | Phillips Bryan K | -735 | $59.53 | $43,755 |
| 2026-02-20 | Phillips Bryan K | +2,400 | - | - |
| 2026-02-13 | Buchholz Richard | -579 | $59.76 | $34,601 |
| 2026-02-13 | Herbert Timothy P. | -1,635 | $59.76 | $97,708 |
| 2026-02-13 | Mann Melissa | -615 | $59.76 | $36,752 |
| 2026-02-13 | Rondoni John | -587 | $59.76 | $35,079 |
| 2026-02-13 | Kelly Jason P | -551 | $59.76 | $32,928 |
| 2026-02-13 | Weatherby Carlton | -570 | $59.76 | $34,063 |
| 2026-02-13 | Phillips Bryan K | -579 | $59.76 | $34,601 |
| 2026-02-09 | Weatherby Carlton | -327 | $66.33 | $21,690 |
| 2026-02-09 | Herbert Timothy P. | -968 | $66.33 | $64,207 |
| 2026-02-09 | Rondoni John | -327 | $66.33 | $21,690 |
| 2026-02-09 | Buchholz Richard | -327 | $66.33 | $21,690 |
| 2026-02-09 | Phillips Bryan K | -327 | $66.33 | $21,690 |
| 2026-01-15 | Melenikiotou Georgia | +180 | $96.47 | $17,365 |
| 2026-01-15 | Tansey Casey M | +181 | $96.47 | $17,461 |
| 2026-01-15 | Broader Shelley G | +200 | $96.47 | $19,294 |
| 2026-01-15 | Ellis Gary Lee | +304 | $96.47 | $29,327 |
| 2026-01-09 | Rondoni John | -109 | $100 | $10,900 |
| 2025-12-02 | mcCormick Shawn | -1,200 | $139 | $166,800 |
| 2025-11-28 | mcCormick Shawn | -2,000 | $127.48 | $254,960 |
| 2025-10-14 | Melenikiotou Georgia | +229 | $78.84 | $18,054 |
| 2025-10-14 | Tansey Casey M | +221 | $78.84 | $17,424 |
| 2025-10-14 | Broader Shelley G | +245 | $78.84 | $19,316 |
| 2025-10-14 | Ellis Gary Lee | +372 | $78.84 | $29,328 |